| Characteristic | N˚ | % |
| Age (years) Median Range |
45 28 - 65 | |
| Age group (years) <65 ≥65 |
57 3 |
95.0 5.0 |
| ECOG PS 0, I II |
11 49 |
18.3 81.7 |
| Menopausal status Pre/perimenopausal Postmenopausal |
42 18 |
70.0 30.0 |
| Pathological type IDC ILC Others |
52 6 2 |
86.7 10.0 3.3 |
| Tumor Grade Grade I or II Grade III |
54 6 |
90.0 10.0 |
| Biological subtype Luminal A Luminal B & her2 −ve Luminal B & her2 +ve Her2 amplified Triple-negative |
25 5 0 8 22 |
41.7 8.3 0.0 13.3 36.7 |
| Type of metastasis Denovo ABC Recurrent ABC |
8 52 |
13.3 86.7 |
| No of metastasized organ/s One Two or more |
10 50 |
16.6 83.4 |
| Order of PLD line 3rd palliative 4th palliative or more |
16 44 |
26.7 73.3 |
| Chemosensitivity Chemosensitive Chemoresistant |
15 45 |
25.0 75.0 |
| Chemotherapy cycles Total number Mode Range |
296 3 3 - 18 | |